Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Myelin Oligodendrocyte Glycoprotein (MOG) Peptide

MOG Reactivity: Human Host: Synthetic BP, BI
Catalog No. ABIN5685318
  • Target See all MOG products
    MOG (Myelin Oligodendrocyte Glycoprotein (MOG))
    Origin
    Human
    Source
    • 4
    Synthetic
    Application
    Blocking Peptide (BP), BioImaging (BI)
    Characteristics
    MOG peptide corresponds to 12 amino acids of MOG.
  • Application Notes
    MOG Peptide is used for blocking the activity of MOG antibody . The MOG antibody ships at 0.5 mg/mL and the MOG Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    MOG peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
    Storage
    -20 °C
    Storage Comment
    Store at -20°C. When reconstituted minimize freezing and thawing.
  • Target
    MOG (Myelin Oligodendrocyte Glycoprotein (MOG))
    Synonyms
    MOGIG2 Peptide, NRCLP7 Peptide, B230317G11Rik Peptide, MOG Peptide, myelin oligodendrocyte glycoprotein Peptide, MOG Peptide, Mog Peptide
    Gene ID
    4340
    NCBI Accession
    NP_002424, NP_996532, NP_001008229, NP_996535
    OMIM
    56788385
    UniProt
    Q16653
You are here:
Support